Lyra Therapeutics, Inc.
SEC CIK 1327273 · LYRA · last insider filing 2026-05-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Smith W Bradford | Director | filed 2020–2026 |
| Palasis Maria | Director · Principal Executive Officer | filed 2020–2026 |
| Edelman Joseph | Director | filed 2020–2025 |
| Perceptive Advisors LLC | Director | filed 2020–2025 |
| Tobin James R | Director | filed 2022–2025 |
| Merrifield C ANN | Director | filed 2020–2025 |
| Snyderman Nancy Lynn MD | Director | filed 2020–2025 |
| Waksal Harlan | Director · Executive Chair | filed 2022–2024 |
| Poukalov Konstantin | Director | filed 2020–2024 |
| Altman Michael Seth | Director | filed 2020–2024 |
| Anderson Edward T | Director | filed 2020–2023 |
| Whitesides George M | Director | filed 2020–2020 |
| Langer Robert | Director | filed 2020–2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cavalier Jason | Principal Financial Officer | filed 2021–2026 |
| Bishop John E | Chief Technology Officer | filed 2023–2024 |
| Nieman Richard | Chief Medical Officer | filed 2022–2024 |
| Noyes Corinne | See Remarks | filed 2020–2023 |
| Richard Robert E. | SVP, Technical Operations | filed 2020–2023 |
| Nelson Pamela E. | Senior VP, Regulatory Affairs | filed 2020–2022 |
| Elsey R Don | CFO, Treasurer & Secretary | filed 2020–2021 |
| Edgerly-Pflug Laura | See Remarks | filed 2020–2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.